197 related articles for article (PubMed ID: 31986345)
1. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.
Wang Y; Yang Y; Zhang S; Li C; Zhang L
Neurobiol Aging; 2020 Mar; 87():1-10. PubMed ID: 31986345
[TBL] [Abstract][Full Text] [Related]
2. Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats.
Zhao CZ; Zhao B; Zhang XY; Huang XQ; Shi WZ; Liu HL; Fang SH; Lu YB; Zhang WP; Tang FD; Wei EQ
Neuroscience; 2011 Aug; 189():1-11. PubMed ID: 21664436
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice.
Zhang YJ; Zhang L; Ye YL; Fang SH; Zhou Y; Zhang WP; Lu YB; Wei EQ
Acta Pharmacol Sin; 2006 Dec; 27(12):1553-60. PubMed ID: 17112408
[TBL] [Abstract][Full Text] [Related]
4. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.
Ballerini P; Di Iorio P; Ciccarelli R; Caciagli F; Poli A; Beraudi A; Buccella S; D'Alimonte I; D'Auro M; Nargi E; Patricelli P; Visini D; Traversa U
Int J Immunopathol Pharmacol; 2005; 18(2):255-68. PubMed ID: 15888248
[TBL] [Abstract][Full Text] [Related]
5. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
6. A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
Rahman SO; Singh RK; Hussain S; Akhtar M; Najmi AK
Eur J Pharmacol; 2019 Jan; 842():208-220. PubMed ID: 30389631
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of cysteinyl leukotriene receptors on human platelets.
Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
[TBL] [Abstract][Full Text] [Related]
9. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa.
Shirasaki H; Kanaizumi E; Watanabe K; Matsui T; Sato J; Narita S; Rautiainen M; Himi T
Clin Exp Allergy; 2002 Jul; 32(7):1007-12. PubMed ID: 12100046
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
12. A new CysLT
Sekioka T; Kadode M; Osakada N; Fujita M; Matsumura N; Yamaura Y; Nakade S; Nabe T; Kawabata K
Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():18-24. PubMed ID: 28410666
[TBL] [Abstract][Full Text] [Related]
13. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene receptors.
Evans JF
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
[TBL] [Abstract][Full Text] [Related]
15. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
[TBL] [Abstract][Full Text] [Related]
16. A review on leukotrienes and their receptors with reference to asthma.
Singh RK; Tandon R; Dastidar SG; Ray A
J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
[TBL] [Abstract][Full Text] [Related]
17. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis.
Figueroa DJ; Borish L; Baramki D; Philip G; Austin CP; Evans JF
Clin Exp Allergy; 2003 Oct; 33(10):1380-8. PubMed ID: 14519144
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene receptors in rhinitis and sinusitis.
Steinke JW; Borish L
Curr Allergy Asthma Rep; 2004 May; 4(3):217-23. PubMed ID: 15056404
[TBL] [Abstract][Full Text] [Related]
19. Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT₁-G300S and CysLT₁-I206S.
Yaddaden L; Véronneau S; Thompson MD; Rola-Pleszczynski M; Stankova J
Prostaglandins Leukot Essent Fatty Acids; 2016 Feb; 105():1-8. PubMed ID: 26869085
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells.
Uzonyi B; Lötzer K; Jahn S; Kramer C; Hildner M; Bretschneider E; Radke D; Beer M; Vollandt R; Evans JF; Funk CD; Habenicht AJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6326-31. PubMed ID: 16606835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
